Mountain West Business Solutions, Inc. recently announced that the company has acquired Sunshine Biopharma, Inc. Based in Colorado, Sunshine Biopharma is a leading pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer. Mountain West Business Solutions intends to change its name to Sunshine Biopharma, Inc. to reflect the company’s new direction. In addition, Mountain West Business Solutions’ trading symbol will also be changed upon the name change taking effect.

According to the terms of the deal, the acquisition was in exchange for the issuance of 21,962,000 shares of common stock and 850,000 shares of Series “A” convertible preferred stock. Each preferred share can be converted into 20 shares of common stock.

Mountain West Business Solutions also announced that Dr. Steve N. Slilaty has been named chairman, president and chief executive officer; Michele di Turi as chief operating officer and director; and Camille Sebaaly as chief financial officer, secretary and director. These positions were filled to replace former management who resigned upon completion of the acquisition.